ICH Q12: innovadora y controvertida (parte 2)

This work has been published in two parts. In the first, the conceptual framework of the ICH and more specifically of the ICH Q12 was reviewed. In this second, and last, the regulatory and enabling tools of the ICH Q12 are reviewed, which is complemented by a practical part or 'survey' car...

Descripción completa

Detalles Bibliográficos
Autores: Monsonís Centelles, Laura, García Montoya, Encarna
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/183451
Acceso en línea:https://hdl.handle.net/2445/183451
Access Level:acceso abierto
Palabra clave:Tecnologia farmacèutica
Comprimits (Medicina)
Desenvolupament de medicaments
Pharmaceutical technology
Tablets (Medicine)
Drug development
id ES_56edb985a18aa50dea6ef577d0de1b3a
oai_identifier_str oai:recercat.cat:2445/183451
network_acronym_str ES
network_name_str España
repository_id_str
spelling ICH Q12: innovadora y controvertida (parte 2)Monsonís Centelles, LauraGarcía Montoya, EncarnaTecnologia farmacèuticaComprimits (Medicina)Desenvolupament de medicamentsPharmaceutical technologyTablets (Medicine)Drug developmentThis work has been published in two parts. In the first, the conceptual framework of the ICH and more specifically of the ICH Q12 was reviewed. In this second, and last, the regulatory and enabling tools of the ICH Q12 are reviewed, which is complemented by a practical part or 'survey' carried out with some professionals in the pharmaceutical industry, although the sample is very small and cannot be generalized, It is important to realize that more information and training on it is necessary at this time for its effective application.Infoedita2022202220212022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion12 p.application/pdfapplication/pdfhttps://hdl.handle.net/2445/183451Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)EspañolReproducció del document publicat a: https://https://www.pharmatech.es/kiosco/revista60#.Ye507OrMPharmatech, 2021, num. 60, p. 80-91(c) Infoedita, 2021info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1834512026-05-29T05:05:01Z
dc.title.none.fl_str_mv ICH Q12: innovadora y controvertida (parte 2)
title ICH Q12: innovadora y controvertida (parte 2)
spellingShingle ICH Q12: innovadora y controvertida (parte 2)
Monsonís Centelles, Laura
Tecnologia farmacèutica
Comprimits (Medicina)
Desenvolupament de medicaments
Pharmaceutical technology
Tablets (Medicine)
Drug development
title_short ICH Q12: innovadora y controvertida (parte 2)
title_full ICH Q12: innovadora y controvertida (parte 2)
title_fullStr ICH Q12: innovadora y controvertida (parte 2)
title_full_unstemmed ICH Q12: innovadora y controvertida (parte 2)
title_sort ICH Q12: innovadora y controvertida (parte 2)
dc.creator.none.fl_str_mv Monsonís Centelles, Laura
García Montoya, Encarna
author Monsonís Centelles, Laura
author_facet Monsonís Centelles, Laura
García Montoya, Encarna
author_role author
author2 García Montoya, Encarna
author2_role author
dc.subject.none.fl_str_mv Tecnologia farmacèutica
Comprimits (Medicina)
Desenvolupament de medicaments
Pharmaceutical technology
Tablets (Medicine)
Drug development
topic Tecnologia farmacèutica
Comprimits (Medicina)
Desenvolupament de medicaments
Pharmaceutical technology
Tablets (Medicine)
Drug development
description This work has been published in two parts. In the first, the conceptual framework of the ICH and more specifically of the ICH Q12 was reviewed. In this second, and last, the regulatory and enabling tools of the ICH Q12 are reviewed, which is complemented by a practical part or 'survey' carried out with some professionals in the pharmaceutical industry, although the sample is very small and cannot be generalized, It is important to realize that more information and training on it is necessary at this time for its effective application.
publishDate 2021
dc.date.none.fl_str_mv 2021
2022
2022
2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/183451
url https://hdl.handle.net/2445/183451
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://https://www.pharmatech.es/kiosco/revista60#.Ye507OrM
Pharmatech, 2021, num. 60, p. 80-91
dc.rights.none.fl_str_mv (c) Infoedita, 2021
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Infoedita, 2021
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 12 p.
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Infoedita
publisher.none.fl_str_mv Infoedita
dc.source.none.fl_str_mv Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408415251431424
score 15.198674

Similares en LA Referencia